U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
194311194311Capecitabine in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone TherapyCompletedNo Results AvailableProstate CancerDrug: capecitabinehttps://ClinicalTrials.gov/show/NCT00006023
194312194312Interleukin-2 Plus Bryostatin 1 in Treating Patients With Melanoma or Kidney CancerCompletedNo Results AvailableKidney Cancer|Melanoma (Skin)Biological: aldesleukin|Drug: bryostatin 1https://ClinicalTrials.gov/show/NCT00006022
194313194313Arsenic Trioxide Plus Vitamin C in Treating Patients With Recurrent or Refractory Multiple MyelomaCompletedNo Results AvailableMultiple Myeloma and Plasma Cell NeoplasmDietary Supplement: ascorbic acid|Drug: arsenic trioxidehttps://ClinicalTrials.gov/show/NCT00006021
194314194314S0010 506U78 in Treating Patients With Recurrent or Refractory Acute Lymphocytic LeukemiaCompletedNo Results AvailableLeukemiaDrug: nelarabinehttps://ClinicalTrials.gov/show/NCT00006020
194315194315Phenylbutyrate Plus Azacitidine in Treating Patients With Acute Myeloid Leukemia, Myelodysplasia, Non-Hodgkin's Lymphoma, Multiple Myeloma, Non-small Cell Lung Cancer, or Prostate CancerCompletedNo Results AvailableLeukemia|Lung Cancer|Lymphoma|Multiple Myeloma and Plasma Cell Neoplasm|Myelodysplastic Syndromes|Prostate CancerDrug: azacitidine|Drug: sodium phenylbutyratehttps://ClinicalTrials.gov/show/NCT00006019
194316194316Paclitaxel and BMS-214662 in Treating Patients With Advanced Solid TumorsCompletedNo Results AvailableUnspecified Adult Solid Tumor, Protocol SpecificDrug: BMS-214662|Drug: paclitaxelhttps://ClinicalTrials.gov/show/NCT00006018
194317194317Two Rebeccamycin Analogue Regimens in Treating Patients With Advanced or Recurrent Non-small Cell Lung CancerCompletedNo Results AvailableLung CancerDrug: becatecarinhttps://ClinicalTrials.gov/show/NCT00006017
194318194318Thalidomide and Chemoembolization With Doxorubicin in Treating Patients With Liver Cancer That Cannot be Removed by SurgeryCompletedNo Results AvailableAdult Primary Hepatocellular Carcinoma|Advanced Adult Primary Liver Cancer|Localized Unresectable Adult Primary Liver CancerDrug: thalidomide|Drug: doxorubicin hydrochloride|Other: laboratory biomarker analysishttps://ClinicalTrials.gov/show/NCT00006016
194319194319Combination Chemotherapy Plus Trastuzumab in Treating Patients With Advanced, Recurrent, or Metastatic Colorectal CancerTerminatedNo Results AvailableColorectal CancerBiological: trastuzumab|Drug: fluorouracil|Drug: leucovorin calcium|Drug: oxaliplatinhttps://ClinicalTrials.gov/show/NCT00006015
194320194320SU5416 in Treating Patients With Malignant MesotheliomaCompletedNo Results AvailableMalignant MesotheliomaDrug: semaxanibhttps://ClinicalTrials.gov/show/NCT00006014
194321194321SU5416 in Treating Patients With Refractory or Relapsed Multiple MyelomaCompletedNo Results AvailableMultiple Myeloma and Plasma Cell NeoplasmDrug: semaxanibhttps://ClinicalTrials.gov/show/NCT00006013
194322194322Combination Chemotherapy and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung CancerCompletedNo Results AvailableDrug/Agent Toxicity by Tissue/Organ|Lung Cancer|Radiation ToxicityBiological: filgrastim|Drug: amifostine trihydrate|Drug: cisplatin|Drug: etoposide|Drug: paclitaxel|Drug: topotecan hydrochloride|Radiation: radiation therapyhttps://ClinicalTrials.gov/show/NCT00006012
194323194323Comparison of Two Combination Chemotherapy Regimens Plus Radiation Therapy in Treating Patients With Stage III or Stage IV Endometrial CancerCompletedHas ResultsEndometrial Adenocarcinoma|Endometrial Adenosquamous Carcinoma|Endometrial Clear Cell Adenocarcinoma|Endometrial Endometrioid Adenocarcinoma, Variant With Squamous Differentiation|Endometrial Serous Adenocarcinoma|Stage III Uterine Corpus CancerDrug: Doxorubicin Hydrochloride|Drug: Cisplatin|Biological: Filgrastim|Biological: Pegfilgrastim|Drug: Paclitaxelhttps://ClinicalTrials.gov/show/NCT00006011
194324194324Gemcitabine Plus Docetaxel in Treating Patients With Unresectable or Metastatic Liver CancerCompletedNo Results AvailableLiver CancerDrug: docetaxel|Drug: gemcitabine hydrochloridehttps://ClinicalTrials.gov/show/NCT00006010
194325194325Monoclonal Antibody Therapy in Treating Patients With Advanced or Recurrent LymphomaCompletedNo Results AvailableLymphoma|Small Intestine CancerBiological: visilizumabhttps://ClinicalTrials.gov/show/NCT00006009
194326194326Arsenic Trioxide in Treating Patients With Relapsed or Refractory Acute Lymphoblastic LeukemiaCompletedNo Results AvailableLeukemiaDrug: arsenic trioxidehttps://ClinicalTrials.gov/show/NCT00006008
194327194327LY231514 Plus Gemcitabine in Treating Women With Metastatic Breast CancerCompletedNo Results AvailableBreast CancerDrug: gemcitabine hydrochloride|Drug: pemetrexed disodiumhttps://ClinicalTrials.gov/show/NCT00006007
194328194328Thalidomide Plus Interferon Alfa in Treating Patients With Progressive Liver Cancer That Cannot be Surgically RemovedCompletedNo Results AvailableLiver CancerBiological: recombinant interferon alfa|Drug: thalidomidehttps://ClinicalTrials.gov/show/NCT00006006
194329194329Thalidomide in Treating Patients With Gynecologic SarcomasCompletedNo Results AvailableEndometrial Cancer|SarcomaDrug: thalidomidehttps://ClinicalTrials.gov/show/NCT00006005
194330194330Comparison of Two Combination Chemotherapy Regimens in Treating Non-small Cell Lung CancerCompletedNo Results AvailableLung CancerDrug: carboplatin|Drug: cisplatin|Drug: gemcitabine hydrochloride|Drug: paclitaxelhttps://ClinicalTrials.gov/show/NCT00006004
194331194331SU5416 in Treating Patients With Metastatic Melanoma That Has Been Previously TreatedTerminatedNo Results AvailableRecurrent Melanoma|Stage IV MelanomaDrug: semaxanib|Other: laboratory biomarker analysishttps://ClinicalTrials.gov/show/NCT00006003
194332194332SU5416 Compared to Dexamethasone in Treating Patients With Progressive Prostate Cancer That Has Not Responded to Hormone TherapyCompletedNo Results AvailableProstate CancerDrug: dexamethasone|Drug: semaxanibhttps://ClinicalTrials.gov/show/NCT00006002
194333194333SU5416 in Treating Patients With Metastatic or Locally Recurrent Colorectal CancerTerminatedNo Results AvailableColorectal CancerDrug: semaxanibhttps://ClinicalTrials.gov/show/NCT00006001
194334194334SU5416, Irinotecan, and Cisplatin in Treating Patients With Advanced Solid TumorsCompletedNo Results AvailableUnspecified Adult Solid Tumor, Protocol SpecificDrug: cisplatin|Drug: irinotecan hydrochloride|Drug: semaxanibhttps://ClinicalTrials.gov/show/NCT00006000
194335194335Arsenic Trioxide in Treating Patients With Stage IVB or Recurrent Cervical CancerCompletedNo Results AvailableCervical CancerDrug: arsenic trioxidehttps://ClinicalTrials.gov/show/NCT00005999
194336194336Peripheral Stem Cell Transplantation With Specially Treated Stem Cells in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's DiseaseWithdrawnNo Results AvailableLymphomaDrug: carmustine|Drug: cyclophosphamide|Drug: cytarabine|Drug: dexamethasone|Drug: etoposide|Drug: filgrastim|Drug: mitoxantrone hydrochloride|Drug: retrovirus vector LN|Procedure: in vitro-treated peripheral blood stem cell transplantation|Procedure: peripheral blood stem cell transplantation|Procedure: radiation therapyhttps://ClinicalTrials.gov/show/NCT00005998
194337194337Rebeccamycin Analogue in Treating Patients With Advanced Liver and/or Biliary CancerTerminatedNo Results AvailableExtrahepatic Bile Duct Cancer|Gallbladder Cancer|Liver CancerDrug: becatecarinhttps://ClinicalTrials.gov/show/NCT00005997
194338194338SU5416 Combined With Gemcitabine and Cisplatin in Treating Patients With Advanced Solid TumorsActive, not recruitingNo Results AvailableUnspecified Adult Solid Tumor, Protocol SpecificDrug: cisplatin|Drug: gemcitabine hydrochloride|Drug: semaxanibhttps://ClinicalTrials.gov/show/NCT00005996
194339194339AE-941 in Treating Patients With Metastatic Kidney CancerCompletedNo Results AvailableKidney CancerDrug: shark cartilage extract AE-941https://ClinicalTrials.gov/show/NCT00005995
194340194340Patient Education in Preventing Nausea and Vomiting in Cancer Patients Receiving ChemotherapyCompletedNo Results AvailableNausea and Vomiting|Unspecified Adult Solid Tumor, Protocol SpecificDrug: ondansetronhttps://ClinicalTrials.gov/show/NCT00005994

* Görseller ve İçerik tekif hakkına sahip olabilir